Inflammatory
cytokines, such as
tumor necrosis factor (
TNF)-alpha and
interleukin-1 (IL-1), trigger the activation of
transcription factor NF-kappaB that induces the expression of a variety of genes, including
intercellular adhesion molecule (ICAM)-1.
Odoroside A [3beta-O-(beta-D-diginosyl)-14-hydroxy-5beta,14beta-card-20(22)-enolide] was found to inhibit the cell-surface expression of
ICAM-1 induced by
TNF-alpha and
IL-1 at comparable concentrations in human lung
carcinoma A549 cells. In this study, the molecular mechanism underlying the inhibition of
TNF-alpha-induced cell-surface
ICAM-1 expression by
odoroside A together with the specific
Na(+)/K(+)-ATPase inhibitor ouabain was further investigated.
Odoroside A and
ouabain neither prevented
IkappaBalpha degradation nor
NF-kappaB translocation to the nucleus upon
TNF-alpha stimulation. While
odoroside A and
ouabain had no inhibitory effect on the induction of
ICAM-1 mRNA, they inhibited the
TNF-alpha-induced
ICAM-1 expression at the
protein level. Consistent with these results,
odoroside A and
ouabain potently reduced de novo
protein synthesis, largely due to its ability to block Na(+)-dependent transport of
amino acids across the plasma membrane, but not to interfering with the translation machinery. As a direct molecular target,
odoroside A was found to inhibit the
ATP-hydrolyzing activity of Na(+)/K(+)-
ATPase as potently as
ouabain. These results clearly demonstrate that
odoroside A and
ouabain prevent
NF-kappaB-inducible
protein expression by blocking the Na(+)-dependent
amino acid transport.